Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria

Frontiers in Pharmacology
Bruno BragançaPaulo Correia-de-Sá

Abstract

Impulse generation in supraventricular tissue is inhibited by adenosine and acetylcholine via the activation of A1 and M2 receptors coupled to inwardly rectifying GIRK/KIR3.1/3.4 channels, respectively. Unlike M2 receptors, bradycardia produced by A1 receptors activation predominates over negative inotropy. Such difference suggests that other ion currents may contribute to adenosine chronoselectivity. In isolated spontaneously beating rat atria, blockade of KCa2/SK channels with apamin and Cav1 (L-type) channels with nifedipine or verapamil, sensitized atria to the negative inotropic action of the A1 agonist, R-PIA, without affecting the nucleoside negative chronotropy. Patch-clamp experiments in the whole-cell configuration mode demonstrate that adenosine, via A1 receptors, activates the inwardly-rectifying GIRK/KIR3.1/KIR3.4 current resulting in hyperpolarization of atrial cardiomyocytes, which may slow down heart rate. Conversely, the nucleoside inactivates a small conductance Ca(2+)-activated KCa2/SK outward current, which eventually reduces the repolarizing force and thereby prolong action potentials duration and Ca(2+) influx into cardiomyocytes. Immunolocalization studies showed that differences in A1 receptors distribut...Continue Reading

References

Jan 1, 1990·Annual Review of Pharmacology and Toxicology·E C HulmeN J Buckley
Oct 1, 1989·Pflügers Archiv : European journal of physiology·I Baró, D Escande
Aug 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·M J LohseR A Olsson
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M HuguesM Lazdunski
Jun 1, 1993·Pharmacology & Therapeutics·M P Caulfield
Mar 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L BelardinelliM Srinivas
Sep 1, 1994·Cardiovascular Research·G KabellL Belardinelli
Dec 1, 1993·The American Journal of Physiology·H T LeeF L Belloni
Jan 1, 1996·Transplant International : Official Journal of the European Society for Organ Transplantation·J KoglinW von Scheidt
Jan 1, 1996·Pharmacology & Therapeutics·K Lawson
May 1, 1997·Cardiovascular Research·J G Dobson, R A Fenton
Jun 19, 1997·The American Journal of Cardiology·J C Shryock, L Belardinelli
Feb 12, 1998·Neuron·K WickmanD E Clapham
May 13, 1999·The Journal of Biological Chemistry·S A RivkeesZ Zhao
Dec 22, 1999·British Journal of Pharmacology·J NeumannW Schmitz
Sep 15, 2001·Cardiovascular Research·K Mubagwa, W Flameng
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Mitsuhiko Yamada
May 22, 2002·Molecular Pharmacology·Alena Krejcí, Stanislav Tucek
Feb 7, 2003·Current Topics in Medicinal Chemistry·Arvinder K DhallaL Belardinelli
Sep 19, 2003·The Journal of Biological Chemistry·Yanfang XuNipavan Chiamvimonvat
Oct 3, 2003·British Journal of Pharmacology·Alan E LomaxWayne R Giles
Jun 23, 2004·Toxicon : Official Journal of the International Society on Toxinology·Heike Jäger, Stephan Grissmer
Feb 9, 2005·Circulation·Halina DobrzynskiMark R Boyett
Aug 2, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Dipika TutejaNipavan Chiamvimonvat
Nov 18, 2006·Circulation Research·Ling LuNipavan Chiamvimonvat
Jun 3, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Irina Savelieva, John Camm
Jul 16, 2008·Physiological Reviews·Matteo E Mangoni, Joël Nargeot
May 12, 2009·The Journal of Pharmacology and Experimental Therapeutics·T KitazawaJürgen Wess
Jul 28, 2009·Journal of Molecular and Cellular Cardiology·Norbert NagyAndrás Tóth
Jul 30, 2009·Handbook of Experimental Pharmacology·S Jamal MustafaAmir Pelleg
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·Augustus O Grant
Oct 31, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Ahmad S AminArthur A M Wilde
May 26, 2010·Clinical and Experimental Pharmacology & Physiology·SuYoung HanChris P Bolter
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Oct 12, 2010·Advances in Pharmacology·Gui-Rong Li, Ming-Qing Dong
May 1, 2012·European Journal of Pharmacology·Timothy J Searl, Eugene M Silinsky
Apr 24, 2013·Journal of Cardiovascular Pharmacology·Xiaodong WangThomas Jespersen
Jul 3, 2013·General Physiology and Biophysics·Zsuzsanna KissRudolf Gesztelyi
Aug 22, 2013·British Journal of Pharmacology·Wenjie HeBruce N Cronstein
Jan 27, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jane M HancockNeil V Marrion
Apr 10, 2015·Journal of Cardiovascular Pharmacology·Lasse SkibsbyeThomas Jespersen

Methods Mentioned

BETA
confocal microscopy

Related Concepts

Acetylcholine
Adenosine
Receptors, Purinergic P1
Apamin
Calcium Channel
Mental Depression
Heart Atrium
IgA1
Ion Channel
Ions

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.